Related Experiment Video
Updated: Apr 13, 2026

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
Published on: January 7, 2019
Potential of Mesenchymal Stem Cell based application in Cancer
Sushilkumar Ramdasi1, Shabari Sarang1, Chandra Viswanathan1
1Regenerative Medicine Group, Reliance Life Sciences Pvt. Ltd. Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai - 400701. India.
Mesenchymal stem cells (MSCs) show anti-tumor potential, migrating to tumors and potentially delivering therapeutic agents. Their role in cancer is complex, but they may induce cancer cell death via TRAIL.
Area of Science:
- Oncology
- Stem Cell Biology
- Immunology
Background:
- Mesenchymal stem cells (MSCs) are investigated for cancer treatment due to their tumor-homing ability and immune-privileged nature.
- MSCs can exhibit both pro-tumorigenic and anti-tumorigenic effects within the tumor microenvironment, influenced by various factors.
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) secreted by MSCs shows potential for inducing cancer cell apoptosis.
Purpose of the Study:
- To review the dual role of MSCs in cancer, examining both their tumor-promoting and tumor-suppressing properties.
- To explore the potential of MSCs, particularly those derived from umbilical cord tissue, in delivering anti-cancer therapies.
- To investigate the expression of TRAIL by MSCs in co-culture systems and its effect on cancer cell apoptosis.
Main Methods:
- Review of existing literature on MSCs and their interactions with various cancer cell lines.
- Analysis of studies investigating MSCs' tumor tropism and therapeutic agent delivery capabilities.
- Examination of research on MSC-secreted factors, focusing on TRAIL's role in apoptosis induction.
Main Results:
- MSCs possess properties advantageous for cancer therapy, including tumor site migration and potential for differentiation.
- The influence of MSCs on cancer progression is context-dependent, varying with MSC source, cancer type, and microenvironmental factors.
- Studies suggest that MSCs can upregulate TRAIL expression, leading to apoptosis in co-cultured cancer cells, particularly those derived from umbilical cord tissue.
Conclusions:
- MSCs present a promising platform for cancer treatment, with their anti-tumorigenic functions being a key area of research.
- Further investigation into umbilical cord tissue-derived MSCs and their TRAIL expression is warranted for therapeutic development.
- Understanding the complex interplay between MSCs and the tumor microenvironment is crucial for optimizing their anti-cancer potential.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10:18Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Culture